Status:
COMPLETED
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
Lead Sponsor:
Hamdard University
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to evaluate the impact of clinical pharmacist interventions on treatment outcomes, health-related quality of life (HRQoL),and medication adherence among chronic k...
Detailed Description
This is a randomized, pharmacist-led, two-group, longitudinal descriptive intervention study performed at a private hospital nephrology department. The study included the introduction of clinical phar...
Eligibility Criteria
Inclusion
- All male and female inpatients and outpatients with chronic kidney disease defined as a creatinine clearance (CrCl) less than 60 ml/min/l, 73 m2
- over the age of 18 years , will be included in study.
- Patient who are on maintenance hemodialysis also included.
Exclusion
- Patients with acute renal failure
- Patients who are receiving renal transplants will not be included.
- Patients who will refuse to participate in study will not be included.
Key Trial Info
Start Date :
September 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06071065
Start Date
September 22 2023
End Date
May 20 2024
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akbar Niazi Teaching Hospital
Islamabad, Islamabad, Pakistan